Topical rapamycin (sirolimus) for the treatment of uncomplicated tufted angiomas in two children and review of the literature.
Pediatr Dermatol
; 35(5): e286-e290, 2018 Sep.
Article
em En
| MEDLINE
| ID: mdl-30015406
ABSTRACT
The mTOR inhibitor rapamycin is used systemically for the treatment of vascular lesions. We report the first use of topical rapamycin for the successful treatment of two cases of tufted angioma. The evidence for the use of topical rapamycin in other dermatologic conditions is summarized to aid in clinical decision making on preparations and anticipated side effects.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Cutâneas
/
Sirolimo
/
Hemangioma
/
Imunossupressores
Tipo de estudo:
Prognostic_studies
Limite:
Child
/
Female
/
Humans
/
Infant
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article